Opyl Limited (ASX:OPL – Get Free Report) insider Antanas (Tony) Guoga purchased 1,500,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 11th. The stock was bought at an average cost of A$0.03 ($0.02) per share, with a total value of A$45,000.00 ($28,481.01).
Opyl Stock Performance
About Opyl
Opyl Limited develops digital tools that enhance healthcare experience for patients in Australia. The company also delivers deep market insights from social media data and enhance clinical research process. It offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials.
Recommended Stories
- Five stocks we like better than Opyl
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- Market Cap Calculator: How to Calculate Market Cap
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Opyl Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opyl and related companies with MarketBeat.com's FREE daily email newsletter.
